Universe Pharmaceuticals (UPC) Assets (2020 - 2025)
Universe Pharmaceuticals' Assets history spans 6 years, with the latest figure at $69.3 billion for Q3 2025.
- On a quarterly basis, Assets rose 1.99% to $69.3 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $69.3 billion, a 1.99% increase, with the full-year FY2025 number at $69.3 billion, up 1.99% from a year prior.
- Assets hit $69.3 billion in Q3 2025 for Universe Pharmaceuticals, up from $68.0 billion in the prior quarter.
- Over the last five years, Assets for UPC hit a ceiling of $69.3 billion in Q3 2025 and a floor of $41.7 million in Q3 2023.
- Historically, Assets has averaged $17.2 billion across 5 years, with a median of $70.3 million in 2021.
- Biggest five-year swings in Assets: skyrocketed 243521825.1% in 2021 and later fell 29.92% in 2023.
- Tracing UPC's Assets over 5 years: stood at $70.1 million in 2021, then fell by 15.12% to $59.5 million in 2022, then fell by 29.92% to $41.7 million in 2023, then skyrocketed by 162762.16% to $68.0 billion in 2024, then grew by 1.99% to $69.3 billion in 2025.
- Business Quant data shows Assets for UPC at $69.3 billion in Q3 2025, $68.0 billion in Q3 2024, and $49.4 million in Q1 2024.